Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Ironwood Pharmaceuticals (IRWD) Asset Utilization Ratio (2016 - 2025)

Ironwood Pharmaceuticals (IRWD) has disclosed Asset Utilization Ratio for 15 consecutive years, with 0.75 as the latest value for Q4 2025.

  • Quarterly Asset Utilization Ratio fell 21.31% to 0.75 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 0.75 through Dec 2025, down 21.31% year-over-year, with the annual reading at 0.79 for FY2025, 7.37% down from the prior year.
  • Asset Utilization Ratio hit 0.75 in Q4 2025 for Ironwood Pharmaceuticals, down from 0.92 in the prior quarter.
  • In the past five years, Asset Utilization Ratio ranged from a high of 0.96 in Q3 2024 to a low of 0.37 in Q1 2023.
  • Historically, Asset Utilization Ratio has averaged 0.67 across 5 years, with a median of 0.72 in 2025.
  • Biggest five-year swings in Asset Utilization Ratio: plummeted 53.56% in 2021 and later surged 145.79% in 2024.
  • Year by year, Asset Utilization Ratio stood at 0.38 in 2021, then increased by 2.27% to 0.38 in 2022, then soared by 131.97% to 0.89 in 2023, then increased by 6.68% to 0.95 in 2024, then fell by 21.31% to 0.75 in 2025.
  • Business Quant data shows Asset Utilization Ratio for IRWD at 0.75 in Q4 2025, 0.92 in Q3 2025, and 0.92 in Q2 2025.